Boye, K. S. et al. Utilities and disutilities for attributes of injectable treatments for type 2 diabetes. Eur. J. Heal. Econ. 12, 219–230 (2011).
Google Scholar
Pratley, R. E. et al. Liraglutide versus sitagliptin for patients with type 2 diabetes who did not have adequate glycaemic control with metformin: a 26-week, randomised, parallel-group, open-label trial. Lancet 375, 1447–1456 (2010).
Google Scholar
Turner, R. C., Cull, C. A., Frighi, V. & Holman, R. R.Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group. JAMA 281, 2005–2012 (1999).
Google Scholar
Colombel, J. F. et al. Adalimumab for maintenance of clinical response and remission in patients with Crohn’s disease: the CHARM trial. Gastroenterology 132, 52–65 (2007).
Google Scholar
Brayden, D. J. & Alonso, M.-J. Oral delivery of peptides: opportunities and issues for translation. Adv. Drug Deliv. Rev. 106, 193–195 (2016).
Google Scholar
Drucker, D. J. Advances in oral peptide therapeutics. Nat. Rev. Drug Discov. 19, 277–289 (2019).
Rubino, A., McQuay, L. J., Gough, S. C., Kvasz, M. & Tennis, P. Delayed initiation of subcutaneous insulin therapy after failure of oral glucose-lowering agents in patients with type 2 diabetes: a population-based analysis in the UK. Diabet. Med. 24, 1412–1418 (2007).
Google Scholar
Ruemmele, F. M. et al. Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn’s disease. J. Crohn’s Colitis 8, 1179–1207 (2014).
Google Scholar
Ahadian, S. et al. Micro and nanoscale technologies in oral drug delivery. Adv. Drug Deliv. Rev. 157, 37–62 (2020).
Anselmo, A. C., Gokarn, Y. & Mitragotri, S. Non-invasive delivery strategies for biologics. Nat. Rev. Drug Discov. 18, 19–40 (2018).
Google Scholar
Buckley, S. T. et al. Transcellular stomach absorption of a derivatized glucagon-like peptide-1 receptor agonist. Sci. Transl. Med. 10, eaar7047 (2018).
Google Scholar
Pratley, R. et al. Oral semaglutide versus subcutaneous liraglutide and placebo in type 2 diabetes (PIONEER 4): a randomised, double-blind, phase 3a trial. Lancet 394, 39–50 (2019).
Google Scholar
Husain, M. et al. Oral semaglutide and cardiovascular outcomes in patients with type 2 diabetes. N. Engl. J. Med. 381, 841–851 (2019).
Google Scholar
Halberg, I. B. et al. Efficacy and safety of oral basal insulin versus subcutaneous insulin glargine in type 2 diabetes: a randomised, double-blind, phase 2 trial. Lancet Diabetes Endocrinol. 7, 179–188 (2019).
Google Scholar
Abramson, A., Halperin, F., Kim, J. & Traverso, G. Quantifying the value of orally delivered biologic therapies: a cost-effectiveness analysis of oral semaglutide. J. Pharm. Sci. 108, 3138–3145 (2019).
Google Scholar
Mahmood, A. & Bernkop-Schnürch, A. SEDDS: a game changing approach for the oral administration of hydrophilic macromolecular drugs. Adv. Drug Deliv. Rev. 142, 91–101 (2019).
Google Scholar
Phan, T. N. Q., Shahzadi, I. & Bernkop-Schnürch, A. Hydrophobic ion-pairs and lipid-based nanocarrier systems: the perfect match for delivery of BCS class 3 drugs. J. Controlled Release 304, 146–155 (2019).
Google Scholar
Fox, C. B. et al. Fabrication of sealed nanostraw microdevices for oral drug delivery. ACS Nano 10, 5873–5881 (2016).
Google Scholar
Banerjee, A., Wong, J., Gogoi, R., Brown, T. & Mitragotri, S. Intestinal micropatches for oral insulin delivery. J. Drug Target. 25, 608–615 (2017).
Google Scholar
Melmed, S. et al. Safety and efficacy of oral octreotide in acromegaly: results of a multicenter phase III trial. J. Clin. Endocrinol. Metab. 100, 1699–1708 (2015).
Google Scholar
Abramson, A. et al. An ingestible self-orienting system for oral delivery of macromolecules. Science 363, 611–615 (2019).
Google Scholar
Abramson, A. et al. A luminal unfolding microneedle injector for oral delivery of macromolecules. Nat. Med. 25, 1512–1518 (2019).
Google Scholar
Hashim, M. et al. Jejunal wall delivery of insulin via an ingestible capsule in anesthetized swine—a pharmacokinetic and pharmacodynamic study. Pharmacol. Res. Perspect. 7, e00522 (2019).
Google Scholar
Dhalla, A. K. et al. A robotic pill for oral delivery of biotherapeutics: safety, tolerability, and performance in healthy subjects. Drug Deliv. Transl. Res. https://doi.org/10.1007/s13346-021-00938-1 (2021).
Banerjee, A. et al. Ionic liquids for oral insulin delivery. Proc. Natl Acad. Sci. USA 115, 7296–7301 (2018).
Google Scholar
Angsantikul, P. et al. Ionic liquids and deep eutectic solvents for enhanced delivery of antibodies in the gastrointestinal tract. Adv. Funct. Mater. https://doi.org/10.1002/adfm.202002912 (2020).
Mathiowitz, E. et al. Biologically erodable microspheres as potential oral drug delivery systems. Nature 386, 410–414 (1997).
Google Scholar
Lamson, N. G., Berger, A., Fein, K. C. & Whitehead, K. A. Anionic nanoparticles enable the oral delivery of proteins by enhancing intestinal permeability. Nat. Biomed. Eng. 4, 84–96 (2020).
Google Scholar
Bolondi, L. et al. Measurement of gastric emptying time by real-time ultrasonography. Gastroenterology 89, 752–759 (1985).
Google Scholar
Derrickson, B. H. & Tortora, G. J. Principles of Anatomy and Physiology (Wiley, 2008).
Várkonyi, P. L. & Domokos, G. Mono-monostatic bodies: the answer to Arnold’s question. Math. Intell. 28, 34–38 (2006).
Google Scholar
Butterworth, J. R., Wright, K., Boulton, R. A., Pathmakanthan, S. & Goh, J. Management of swallowed razor blades— retrieve or wait and see? Gut 53, 475–477 (2004).
Google Scholar
Velitchkov, N. G., Grigorov, G. I., Losanoff, J. E. & Kjossev, K. T. Ingested foreign bodies of the gastrointestinal tract: retrospective analysis of 542 cases. World J. Surg. 20, 1001–1005 (1996).
Google Scholar
Traverso, G. et al. Microneedles for drug delivery via the gastrointestinal tract. J. Pharm. Sci. 104, 362–367 (2015).
Google Scholar
Webb, W. A. Management of foreign bodies of the upper gastrointestinal tract: update. Gastrointest. Endosc. 41, 39–51 (1995).
Google Scholar
Bass, D. M., Prevo, M. & Waxman, D. S. Gastrointestinal safety of an extended-release, nondeformable, oral dosage form (OROS): a retrospective study. Drug Saf. 25, 1021–1033 (2002).
Google Scholar
Ben-Menachem, T. et al. Adverse events of upper GI endoscopy. Gastrointest. Endosc. 76, 707–718 (2012).
Google Scholar
Ginsberg, G. G. Management of ingested foreign objects and food bolus impactions. Gastrointest. Endosc. 41, 33–38 (1995).
Google Scholar
Coffman, C. et al. Particles comprising a therapeutic or diagnostic agent and suspensions and methods of use thereof. US Patent Application 20190374470A1 (2019).
Savjani, K. T., Gajjar, A. K. & Savjani, J. K. Drug solubility: importance and enhancement techniques. ISRN Pharm. 2012, 1–10 (2012).
